RxDoctor Payments Data

Sara Maurer

Adult Health · Waconia, MNNPI 1033650627

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.2%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Medtronic accounts for 78.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,582 and has fallen 95.6% since, to $70 in 2025. Among adult health clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,989in general payments, 2019–2025

Across 28 payments — averaging $71.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Intuity Medical Inc$106
  • Abbott$65
  • Bayer$62
  • Dexcom, Inc.$59
  • Mannkind Corporation$43
  • plus $92 from 3 others

What the payments were for

  • Travel & lodging$1,17859%
  • Food & beverage$73837%
  • Gifts$432%
  • Other$302%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,989 in reported general payments places this provider in the 90th percentile of 233 adult health providers in Minnesota.

See all adult health providers in Minnesota

Medicare billing

Part B allowed, 2024
$31,313
Medicare patients
133
Services billed
647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide253$274,641
TrulicityDulaglutide114$145,565
JardianceEmpagliflozin146$139,546
FarxigaDapagliflozin Propanediol64$55,670
MounjaroTirzepatide32$34,045
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/725$32,263
TradjentaLinagliptin29$30,158
Humulin R U-500 KwikpenInsulin Regular, Human33$29,850
Tresiba Flextouch U-100Insulin Degludec33$25,500
WegovySemaglutide17$24,210
Soliqua 100-33Insulin Glargine/Lixisenatide12$19,045
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$12,583
Fiasp FlextouchInsulin Aspart (Niacinamide)11$10,908
Lantus SolostarInsulin Glargine,hum.Rec.Anlog79$10,178
Novolog FlexpenInsulin Aspart23$5,195

Paid to pharmacies, not to this prescriber.

Other adult health in Waconia

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →